Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Wall Street
Price Targets
Price Targets Summary
Ningbo Menovo Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Ningbo Menovo Pharmaceutical Co Ltd is 21.49 CNY with a low forecast of 21.28 CNY and a high forecast of 22.13 CNY.
Revenue
Forecast
Revenue Estimate
Ningbo Menovo Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.
Operating Income
Forecast
Operating Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 2 years is 72%.
Net Income
Forecast
Net Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is -4%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Ningbo Menovo Pharmaceutical Co Ltd's stock price target?
Price Target
21.49
CNY
According to Wall Street analysts, the average 1-year price target for Ningbo Menovo Pharmaceutical Co Ltd is 21.49 CNY with a low forecast of 21.28 CNY and a high forecast of 22.13 CNY.
What is Ningbo Menovo Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.
What is Ningbo Menovo Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
72%
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 2 years is 72%.
What is Ningbo Menovo Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-4%
For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is -4%.